Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BHC NASDAQ:CRON TSE:DHT.UN NYSEARCA:THCX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBHCBausch Health Cos$5.06-0.1%$5.46$4.93▼$8.69$1.89B0.41.82 million shs1.85 million shsCRONCronos Group$2.68$2.68$1.84▼$3.43$999.72M0.891.19 million shs883,879 shsDHT.UNDRI Healthcare TrustC$18.55C$16.85C$13.13▼C$19.04C$1.02B0.47240160,515 shs18,553 shsTHCXAXS Cannabis ETF$16.60$16.60$14.90▼$25.40$141.07M1.7115,071 shsN/ADon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBHCBausch Health Cos0.00%-5.95%-6.77%+0.60%-15.96%CRONCronos Group0.00%-2.19%+1.90%+5.51%+38.86%DHT.UNDRI Healthcare Trust0.00%+1.26%+14.93%+9.96%+39.16%THCXAXS Cannabis ETF0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBHCBausch Health Cos$5.06-0.1%$5.46$4.93▼$8.69$1.89B0.41.82 million shs1.85 million shsCRONCronos Group$2.68$2.68$1.84▼$3.43$999.72M0.891.19 million shs883,879 shsDHT.UNDRI Healthcare TrustC$18.55C$16.85C$13.13▼C$19.04C$1.02B0.47240160,515 shs18,553 shsTHCXAXS Cannabis ETF$16.60$16.60$14.90▼$25.40$141.07M1.7115,071 shsN/ADon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBHCBausch Health Cos0.00%-5.95%-6.77%+0.60%-15.96%CRONCronos Group0.00%-2.19%+1.90%+5.51%+38.86%DHT.UNDRI Healthcare Trust0.00%+1.26%+14.93%+9.96%+39.16%THCXAXS Cannabis ETF0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBHCBausch Health Cos 1.80Reduce$8.0058.26% UpsideCRONCronos Group 2.20Hold$2.30-14.18% DownsideDHT.UNDRI Healthcare Trust 3.00BuyC$25.5037.47% UpsideTHCXAXS Cannabis ETF 1.99Reduce$16.60N/ACurrent Analyst Ratings BreakdownLatest DHT.UN, BHC, CRON, and THCX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/29/2026CRONCronos Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)5/19/2026DHT.UNDRI Healthcare Trust Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuyC$22.00 ➝ C$23.005/19/2026DHT.UNDRI Healthcare Trust National Bank FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperformC$22.50 ➝ C$23.505/19/2026DHT.UNDRI Healthcare Trust ScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector OutperformC$25.00 ➝ C$30.005/12/2026CRONCronos Group TD SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/4/2026BHCBausch Health Cos Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D) ➝ Sell (D-)4/27/2026BHCBausch Health Cos Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSector Perform$10.00 ➝ $9.004/2/2026DHT.UNDRI Healthcare Trust Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuyC$21.00 ➝ C$22.00(Data available from 6/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBHCBausch Health Cos$10.27B0.18$7.33 per share0.69$1.02 per share4.96CRONCronos Group$146.59M6.82$0.01 per share213.77$3.00 per share0.89DHT.UNDRI Healthcare TrustC$163.77M6.23N/AN/AC$9.32 per share1.99THCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBHCBausch Health Cos$157M-$3.24N/A1.34N/A-11.47%-2,922.77%5.63%7/29/2026 (Estimated)CRONCronos Group-$9.45M$0.01268.27N/AN/A-1.14%-1.26%-1.20%8/6/2026 (Estimated)DHT.UNDRI Healthcare TrustC$9.73M-C$0.90N/AN/AN/A5.02%2.06%4.22%N/ATHCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/AN/ALatest DHT.UN, BHC, CRON, and THCX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/11/2026Q1 2026CRONCronos Group$0.01$0.01N/A$0.04$42.20 million$58.97 million4/29/2026Q1 2026BHCBausch Health Cos$0.81$0.78-$0.03-$3.76$2.37 billion$2.46 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBHCBausch Health CosN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ADHT.UNDRI Healthcare TrustC$0.412.21%N/AN/A N/ATHCXAXS Cannabis ETF$0.724.34%N/AN/AN/ALatest DHT.UN, BHC, CRON, and THCX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/31/2026DHT.UNDRI Healthcare TrustQuarterlyC$0.112.67%3/31/20264/20/20264/20/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBHCBausch Health Cos54.681.320.97CRONCronos GroupN/A21.8720.73DHT.UNDRI Healthcare Trust63.201.36N/ATHCXAXS Cannabis ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBHCBausch Health Cos78.65%CRONCronos Group8.71%DHT.UNDRI Healthcare Trust0.60%THCXAXS Cannabis ETFN/AInsider OwnershipCompanyInsider OwnershipBHCBausch Health Cos20.67%CRONCronos Group7.80%DHT.UNDRI Healthcare Trust0.14%THCXAXS Cannabis ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBHCBausch Health Cos20,300374.02 million296.71 millionOptionableCRONCronos Group450373.03 million343.94 millionOptionableDHT.UNDRI Healthcare TrustN/A55.02 millionN/AN/ATHCXAXS Cannabis ETFN/A8.50 millionN/ANot OptionableDHT.UN, BHC, CRON, and THCX HeadlinesRecent News About These CompaniesAurora Cannabis: Weak Near-Term Outlook But Too Cheap To Ignore - BuyJune 12 at 5:04 AM | seekingalpha.comHerbal Dispatch Completes 452kg Multi Client Medical Cannabis Export Shipment To EuropeJune 9, 2026 | newsfilecorp.comNHerbal Dispatch Completes Export of 261kg of Medical Cannabis to EuropeMay 21, 2026 | newsfilecorp.comNHerbal Dispatch Completes Company Record 500kg Medical Cannabis Export Shipment to EuropeMay 19, 2026 | newsfilecorp.comNAurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis ScienceMay 14, 2026 | prnewswire.comVillage Farms: U.S. Cannabis Optionality (Rating Upgrade)May 13, 2026 | seekingalpha.comGreen Thumb Industries Will Benefit From Medical Cannabis ReschedulingMay 12, 2026 | seekingalpha.comInnovative Industrial Properties: Medical Cannabis Rescheduling Implies Bottoming Tenant Default Risks - Reiterate BuyMay 6, 2026 | seekingalpha.comHerbal Dispatch Launches Next-Generation E-Commerce Platform, Targeting High-Growth $245 Million Insured Medical Cannabis SegmentMay 5, 2026 | newsfilecorp.comNGlow Lifetech Expands Distribution with Two of Canada's Largest Cannabis Retailers, Launches New Product Innovation and Advances National Growth StrategyApril 30, 2026 | newsfilecorp.comNCannabis ETFs: Regulatory Momentum Returns FocusApril 30, 2026 | etftrends.comEHerbal Dispatch Advances U.S. Strategy amid Historic Cannabis Rescheduling ShiftApril 27, 2026 | newsfilecorp.comNAurora Cannabis: Why I Like This StockApril 24, 2026 | seekingalpha.comIM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash FlowMarch 31, 2026 | prnewswire.comCanopy Growth's Apollo Cannabis Clinics Named Best Medical Cannabis ClinicMarch 30, 2026 | businesswire.comHYTN Successfully Releases Cannabis Products in Germany and Accepts ReorderMarch 27, 2026 | globenewswire.comInnovative Industrial Properties: Deeply Undervalued As Cannabis Rescheduling Hits MilestoneMarch 27, 2026 | seekingalpha.comVillage Farms Shows Strong Q4 Performance But Cannabis Sector Remains Weak (Rating Downgrade)March 14, 2026 | seekingalpha.com3 Of The Best Cannabis Stocks In The Sector TodayMarch 9, 2026 | marijuanastocks.comMForget Tilray: This Cash‑Flow Monster Can Outlast Every Cannabis Hype CycleMarch 7, 2026 | fool.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines5 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 20263 Stocks Rallying on Micron's Price Boost: Substance or Hype?By Dan Schmidt | May 28, 2026Micron’s $1 Trillion Memory Melt-UpBy Jeffrey Neal Johnson | May 27, 2026Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?By Jessica Mitacek | June 1, 2026Samsung Joins the $1 Trillion Club as AI Memory Demand ExplodesBy Jessica Mitacek | May 17, 2026DHT.UN, BHC, CRON, and THCX Company DescriptionsBausch Health Cos NYSE:BHC$5.06 -0.01 (-0.10%) Closing price 06/12/2026 03:59 PM EasternExtended Trading$5.06 +0.00 (+0.10%) As of 06/12/2026 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Cronos Group NASDAQ:CRON$2.68 0.00 (0.00%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$2.71 +0.03 (+1.19%) As of 06/12/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.DRI Healthcare Trust TSE:DHT.UNC$18.55 0.00 (0.00%) As of 06/12/2026 04:00 PM EasternDRI Healthcare Trust is managed by DRI Capital Inc. DRI a pioneer in global pharmaceutical royalty monetization. We provide uniquely favorable exposure for investors in the biopharma industry managing a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world and aiming to acquire dependable patent-protected cash flow streams derived from the sales of those important drugs while limiting the risks and costs connected to drug development. DRI has developed a disciplined strategy predicated on actively sourcing royalty streams on medically necessary products and proudly work with multiple repeat deal partners.DRI Healthcare Trust is an unincorporated open-ended trust governed by the laws of the Province of Ontario pursuant to a declaration of trust dated October 21 2020 as amended.DRI Healthcare Trusts units are listed and trade on the Toronto Stock Exchange under DHT.UN in Canadian dollars and under DHT.U in U.S. dollars.AXS Cannabis ETF NYSEARCA:THCX$16.60 0.00 (0.00%) As of 03/1/2024The Cannabis ETF (THCX) is an exchange-traded fund that is based on the AXS Cannabis index. The fund tracks an index of legal cannabis companies selected and weighted by market capitalization. The fund primarily holds North American companies but may also invest in other countries. THCX was launched on Jul 9, 2019 and is managed by AXS Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? Alphabet's Most Overlooked Division Just Had a Big Week Robinhood Wants a Bigger Role in IPOs—Here's Why It Matters Viasat's Orbiting Profits: Space Force Jackpot? What to Expect From Q2 Earnings as Tech Strength Broadens ERock IPO: A $1.3B Power Play Solution TJX: Retail’s Apex Predator Feasts on Inflation Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
